Could you summarise the journal article at the provided URL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Infection Control in Bronchoscopy: Historical Contamination Sources and Evolving Pathogen Patterns

Overview of Contamination Mechanisms

This 2003 American Thoracic Society review systematically catalogs the diverse sources of bronchoscope contamination and documents concerning trends in pathogen transmission, including breakthrough infections occurring despite adherence to established reprocessing guidelines. 1

Key Findings on Pathogen Transmission

Breakthrough Infections Despite Protocol Adherence

  • Multiple outbreaks occurred even when current (2003) reprocessing standards were rigorously followed, with 20-43 possible true infections and up to three deaths primarily caused by Pseudomonas aeruginosa 1
  • The causative mechanism involved defective equipment design—specifically loose fittings over valve stems for working channels in certain bronchoscope models—making effective mechanical cleaning and disinfection impossible 1
  • The retrospective nature of these investigations made it difficult to determine exact attribution, as DNA fingerprints from many clinical isolates did not match bronchoscope samples 1

Temporal Trends in Contamination Patterns

The spectrum of contaminating organisms has shifted dramatically over time, reflecting both improved disinfection practices and the emergence of resistant pathogens: 1

  • 1970s-1980s: Diverse bacterial species including Klebsiella and Serratia species predominated 1
  • Mid-1980s onward: P. aeruginosa, fungi, and mycobacteria became the dominant organisms 1

This evolution suggests that while disinfection techniques have improved, certain organisms demonstrate resistance to all but the most rigorous cleaning and powerful disinfectants 1

Comprehensive Contamination Sources

Equipment-Related Failures

Bronchoscope structural issues:

  • Inadequate cleaning of internal channels 1
  • Damaged internal channels preventing effective disinfection 1
  • Poorly-mated internal components creating hidden contamination reservoirs 1
  • Reusable suction valves, suction channels, and biopsy ports 1

Accessory contamination:

  • Sample collection tubing 1
  • Reused stopcocks for bronchoalveolar lavage fluid aspiration 1

Reprocessing Equipment Contamination

Automated reprocessing systems have emerged as a significant modern contamination source: 1

  • Contaminated automated washers, rinsing tanks, and associated tubing 1
  • Biofilm formation within reprocessors 1
  • Contaminated filters and cleaning brushes 1

Solution and Chemical Failures

  • Topical anesthetics (including cocaine and green dye additives) and contaminated atomizers 1
  • Inadequate disinfectant activity (e.g., iodides) 1
  • Incorrect disinfectant concentrations dispensed by automated reprocessors 1
  • Contaminated glutaraldehyde solutions 1
  • Improper connectors to reprocessing equipment 1

Post-Disinfection Recontamination

Critical vulnerabilities after the disinfection process:

  • Rinsing with contaminated tap water from hospital supplies 1
  • Contaminated tap water filters 1
  • Reuse of "sterile water" for rinsing 1
  • Premature reassembly of valves before storage 1
  • Storage in coiled positions or within cases 1

Evolution of Contamination Mechanisms

The nature of contamination sources has fundamentally changed over the review period: 1

  • Earlier reports predominantly described use of ineffective disinfectants or inadequate cleaning regimens 1
  • More recent reports increasingly identify contaminated automated endoscope reprocessors and breaches in pre-established infection control protocols based on guidelines 1

Clinical Implications

Pseudoinfections vs. True Infections

Pseudoinfections—false-positive cultures from contaminated equipment—create significant clinical problems: 1

  • Unnecessary patient anxiety and concern 1
  • Unwarranted antimicrobial treatment 1
  • Delays in diagnosing actual disease 1

Reporting and Surveillance Concerns

The documented cases likely represent only a fraction of actual contamination events, as many institutions may have experienced similar pathogen transmission that went unnoticed or unreported 1

Critical Takeaways for Practice

  • Equipment design flaws can render even perfect adherence to protocols ineffective, necessitating vigilance for manufacturer recalls and equipment modifications 1
  • Automated reprocessing equipment requires its own rigorous maintenance and monitoring to prevent becoming a contamination source 1
  • Post-disinfection handling represents a critical vulnerability, particularly water quality for final rinsing 1
  • The shift toward resistant organisms (Pseudomonas, mycobacteria, fungi) demands increasingly stringent disinfection protocols 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Is the full text of the article on the efficacy of lumbar epidural steroid injections (LESIs) available for free?
Can you summarize medical research articles?
Can you provide free full-text journal articles or studies on invasive melanoma?
Where can a patient read case studies?
In a 50‑year‑old woman with type‑2 diabetes who underwent retrograde intrarenal surgery and double‑J stent placement for a renal calculus and now has refractory postoperative shock with persistent fever despite broad‑spectrum antimicrobial therapy (ceftazidime‑avibactam, aztreonam, fosfomycin, caspofungin, teicoplanin), what is the most urgent next step in management?
What is the recommended treatment and prophylaxis for respiratory syncytial virus (RSV) in infants, including supportive care, aerosolized ribavirin for high‑risk patients (premature ≤35 weeks, chronic lung disease of prematurity, congenital heart disease, immunodeficiency, severe neuromuscular disorders), and monoclonal antibody prophylaxis (palivizumab or nirsevimab)?
What is the diagnosis and immediate management for a double‑bubble sign on prenatal or early‑postnatal ultrasound indicating duodenal atresia?
In a patient with an obstructed infected kidney on ceftazidime‑avibactam, aztreonam, fosfomycin, caspofungin and teicoplanin, with pending repeat blood and urine cultures and a decreasing but still elevated procalcitonin, what is the next best management step?
In a febrile patient, is immersion in cold water or a hot foot soak the preferred method to lower core temperature?
What is the recommended management and delivery plan for a pregnancy in a bicornuate uterus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.